IL-10-conditioned dendritic cells prevent autoimmune diabetes in NOD and humanized HLA-DQ8/RIP-B7.1 mice

Clinical Immunology

Volumn 139, Issue 3, 2011, Pages 336-349

  Tai, Ningwen ^a   Yasuda, Hisafumi ^a,b   Xiang, Yufei ^a   Zhang, Li ^a   Rodriguez Pinto, Daniel ^a   Yokono, Koichi ^b   Sherwin, Robert ^a   Wong, F Susan ^c   Nagata, Masao ^b   Wen, Li ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Autoimmune diabetes; DC therapy; HLA transgenic mouse; IL 10; NOD

Indexed keywords

DENDRITIC CELL VACCINE; HLA DQ8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD80; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; FEMALE; HLA-DQ ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INSULIN-SECRETING CELLS; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTES;

EID: 79955968277     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.03.003     Document Type: Article

References (59)

1. Wen L., Wong F.S., Burkly L., Altieri M., Mamalaki C., Kioussis D., Flavell R.A., Sherwin R.S. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice. J. Clin. Invest. 1998, 102:947-957.
2. Wen L., Wong F.S., Tang J., Chen N.Y., Altieri M., David C., Flavell R., Sherwin R. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J. Exp. Med. 2000, 191:97-104.
3. Wen L., Chen N.Y., Tang J., Sherwin R., Wong F.S. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J. Clin. Invest. 2001, 107:871-880.
4. Wong F.S., Janeway C.A. The role of CD4 vs. CD8 T cells in IDDM. J. Autoimmun. 1999, 13:290-295.
5. Rabinovitch A., Suarez-Pinzon W.L. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem. Pharmacol. 1998, 55:1139-1149.
6. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 2002, 109:131-140.
7. Gregg R.K., Jain R., Schoenleber S.J., Divekar R., Bell J.J., Lee H.H., Yu P., Zaghouani H. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J. Immunol. 2004, 173:7308-7316.
8. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
9. Morel P.A., Feili-Hariri M., Coates P.T., Thomson A.W. Dendritic cells, T cell tolerance and therapy of adverse immune reactions. Clin. Exp. Immunol. 2003, 133:1-10.
10. Diebold S.S. Determination of T-cell fate by dendritic cells. Immunol. Cell Biol. 2008, 86:389-397.
11. Jansen A., Homo-Delarche F., Hooijkaas H., Leenen P.J., Dardenne M., Drexhage H.A. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994, 43:667-675.
12. Dahlen E., Dawe K., Ohlsson L., Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J. Immunol. 1998, 160:3585-3593.
13. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
14. Inaba K., Swiggard W.J., Steinman R.M., Romani N., Schuler G. Isolation of dendritic cells. Curr. Protoc. Immunol. 2009, 86:3.7.1-3.7.19. Chapter 3.
15. Menges M., Baumeister T., Rossner S., Stoitzner P., Romani N., Gessner A., Lutz M.B. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J. Leukoc. Biol. 2005, 77:535-543.
16. Feili-Hariri M., Falkner D.H., Morel P.A. Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur. J. Immunol. 2002, 32:2021-2030.
17. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
18. De Smedt T., Van Mechelen M., De Becker G., Urbain J., Leo O., Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 1997, 27:1229-1235.
19. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 2001, 166:4312-4318.
20. Lee M.S., Wogensen L., Shizuru J., Oldstone M.B., Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J. Clin. Invest. 1994, 93:1332-1338.
21. Wogensen L., Lee M.S., Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med. 1994, 179:1379-1384.
22. Balasa B., Davies J.D., Lee J., Good A., Yeung B.T., Sarvetnick N. IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes. J. Immunol. 1998, 161:4420-4427.
23. Koh J.J., Ko K.S., Lee M., Han S., Park J.S., Kim S.W. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice. Gene Ther. 2000, 7:2099-2104.
24. Goudy K.S., Burkhardt B.R., Wasserfall C., Song S., Campbell-Thompson M.L., Brusko T., Powers M.A., Clare-Salzler M.J., Sobel E.S., Ellis T.M., Flotte T.R., Atkinson M.A. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J. Immunol. 2003, 171:2270-2278.
25. Kundu S.K., Engleman E., Benike C., Shapero M.H., Dupuis M., van Schooten W.C., Eibl M., Merigan T.C. A pilot clinical trial of HIV antigen-pulsed allogeneic and autologous dendritic cell therapy in HIV-infected patients. AIDS Res. Hum. Retroviruses 1998, 14:551-560.
26. Austyn J.M. Antigen-presenting cells. Experimental and clinical studies of dendritic cells. Am. J. Respir. Crit. Care Med. 2000, 162:S146-S150.
27. Mehrotra S., Chhabra A., Chakraborty A., Chattopadhyay S., Slowik M., Stevens R., Zengou R., Mathias C., Butterfield L.H., Dorsky D.I., Economou J.S., Mukherji B., Chakraborty N.G. Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells. Immunology 2004, 113:472-481.
28. Jin Y., Fuller L., Esquenazi V., Blomberg B.B., Burke G.W., Ciancio G., Tzakis A.G., Ricordi C., Miller J. Induction of auto-reactive regulatory T cells by stimulation with immature autologous dendritic cells. Immunol. Invest. 2007, 36:213-232.
29. Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 1988, 18:97-104.
30. Peng J., Dicker B., Du W., Tang F., Nguyen P., Geiger T., Wong F.S., Wen L. Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction. J. Autoimmun. 2007, 28:188-200.
31. Parish C., Warren H. Use of the Intrcellular Fluorescent Dye CFSE to Monitor Lymphocyte Migration and Proliferation 2001, John Wiley and Sons, Inc.
32. Foster B., Prussin C., Liu F., Whitmire J., Whitton J. Detection of Intracellular Cytokines by Flow Cytometry 2007, John Wiley and Sons, Inc.
33. Wong F.S., Karttunen J., Dumont C., Wen L., Visintin I., Pilip I.M., Shastri N., Pamer E.G., Janeway C.A. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 1999, 5:1026-1031.
34. Papaccio G., Nicoletti F., Pisanti F.A., Bendtzen K., Galdieri M. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 2000, 141:1500-1505.
35. Feili-Hariri M., Falkner D.H., Gambotto A., Papworth G.D., Watkins S.C., Robbins P.D., Morel P.A. Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis. Hum. Gene Ther. 2003, 14:13-23.
36. Perone M.J., Bertera S., Tawadrous Z.S., Shufesky W.J., Piganelli J.D., Baum L.G., Trucco M., Morelli A.E. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J. Immunol. 2006, 177:5278-5289.
37. Lo J., Clare-Salzler M.J. Dendritic cell subsets and type I diabetes: focus upon DC-based therapy. Autoimmun. Rev. 2006, 5:419-423.
38. Creusot R.J., Yaghoubi S.S., Kodama K., Dang D.N., Dang V.H., Breckpot K., Thielemans K., Gambhir S.S., Fathman C.G. Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin. Immunol. 2008, 127:176-187.
39. Mukhopadhaya A., Hanafusa T., Jarchum I., Chen Y.G., Iwai Y., Serreze D.V., Steinman R.M., Tarbell K.V., DiLorenzo T.P. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl Acad. Sci. U.S.A. 2008, 105:6374-6379.
40. Obst R., van Santen H.M., Melamed R., Kamphorst A.O., Benoist C., Mathis D. Sustained antigen presentation can promote an immunogenic T cell response, like dendritic cell activation. Proc. Natl Acad. Sci. U.S.A. 2007, 104:15460-15465.
41. Breckpot K., Emeagi P., Dullaers M., Michiels A., Heirman C., Thielemans K. Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Hum. Gene Ther. 2007, 18:536-546.
42. Li C., Goudy K., Hirsch M., Asokan A., Fan Y., Alexander J., Sun J., Monahan P., Seiber D., Sidney J., Sette A., Tisch R., Frelinger J., Samulski R.J. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proc. Natl Acad. Sci. U.S.A. 2009, 106:10770-10774.
43. Harnaha J., Machen J., Wright M., Lakomy R., Styche A., Trucco M., Makaroun S., Giannoukakis N. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells. Diabetes 2006, 55:158-170.
44. Maynard C.L., Weaver C.T. Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. Immunol. Rev. 2008, 226:219-233.
45. Hussain S., Delovitch T.L. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol. 2007, 179:7225-7232.
46. Gregori S., Battaglia M., Roncarolo M.G. Re-establishing immune tolerance in type 1 diabetes via regulatory T cells. Novartis Found. Symp. 2008, 292:174-183. discussion 183-6, 202-3.
47. Gregg R.K., Bell J.J., Lee H.H., Jain R., Schoenleber S.J., Divekar R., Zaghouani H. IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance. J. Immunol. 2005, 174:662-670.
48. Zhang Y.C., Pileggi A., Molano R.D., Wasserfall C., Campbell-Thompson M., Ricordi C., Atkinson M.A., Inverardi L. Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice. Transplantation 2005, 80:530-533.
49. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 1999, 283:1183-1186.
50. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605-617.
51. Wan Y.Y., Flavell R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl Acad. Sci. U.S.A. 2005, 102:5126-5131.
52. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
53. Miyara M., Sakaguchi S. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol. Cell Biol. 2011, 89:1-6.
54. Penna G., Sozzani S., Adorini L. Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J. Immunol. 2001, 167:1862-1866.
55. Penna G., Vulcano M., Roncari A., Facchetti F., Sozzani S., Adorini L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J. Immunol. 2002, 169:6673-6676.
56. Penna G., Vulcano M., Sozzani S., Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 2002, 63:1164-1171.
57. Lotze M.T., Thomson A.W. Dendritic Cells 2001, Academic Press, San Diego.
58. Gunn M.D., Kyuwa S., Tam C., Kakiuchi T., Matsuzawa A., Williams L.T., Nakano H. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999, 189:451-460.
59. Luther S.A., Tang H.L., Hyman P.L., Farr A.G., Cyster J.G. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc. Natl Acad. Sci. U.S.A. 2000, 97:12694-12699.